Due to higher mitochondrion-derived reactive oxygen species (ROS) in CD4+ than CD8+ T lymphocytes, the in vivo blockade of ROS reversed NAFLD-induced CD4+ T-lymphocyte depletion and retarded NAFLD-induced HCC (37). The gene discussed is CD4; the disease is metabolic dysfunction-associated steatotic liver disease.